DD vs VXRT · P/E 127, rev $12.39B vs rev $28.7M
Dupont De Nemours Inc (DD) versus Vaxart Inc (VXRT) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Vaxart Inc (VXRT) is a biotechnology company listed on US.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported VXRT revenue for 2024-12-31 was $28.7M. Net income was -$66.9M. Revenue was up 288.9% from 2023-12-31 to 2024-12-31. VXRT currently screens at market cap $73.0M.
DD currently screens at market cap $19.61B and trailing P/E 127.4. VXRT currently screens at market cap $73.0M.
Not investment advice. Open the DD and VXRT stock pages for the full models.
Not investment advice.